CSF-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.118.254128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

SAT0235 BIIB059, a Monoclonal Antibody Targeting BCDA2 Shows Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteer Subjects

2017English

570 Safety and Efficacy of Bertilimumab, a Human Anti-Eotaxin-1 Monoclonal Antibody, in Bullous Pemphigoid in a Phase 2a Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Safety, Pharmacokinetics, and Immunogenicity of the Combination of the Broadly Neutralizing Anti-Hiv-1 Antibodies 3BNC117 and 10-1074 in Healthy Adults: A Randomized, Phase 1 Study

PLoS ONE
Multidisciplinary
2019English

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials

Journal of Clinical Pharmacology
Pharmacology
2019English

Sustained-Release Ruxolitinib: Findings From a Phase 1 Study in Healthy Subjects and a Phase 2 Study in Patients With Myelofibrosis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2018English

Synthesis of Membrane-Bound Colony-Stimulating Factor 1 (CSF-1) and Downmodulation of CSF-1 Receptors in NIH 3T3 Cells Transformed by Cotransfection of the Human CSF-1 and C-FMS (CSF-1 Receptor) Genes.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1987English

Phase 1 Study of Crisaborole in Japanese Healthy Volunteers and Patients With Atopic Dermatitis

Journal of Dermatology
DermatologyMedicine
2019English

Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine in Healthy HIV-1-Uninfected Adults

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy